Latest Commercialisation News

CMS has finalised higher Medicare inpatient reimbursement for EBR Systems’ WiSE System, lifting base payment rates by up to 93% from 1 October 2026. The change improves the commercial payment pathway, although its financial impact will depend on procedure volumes, hospital adoption and NTAP eligibility.

Jade Gas will use targeted 2D and 3D seismic to test whether its established coal-measure gas system extends into deeper CBM, shale gas and tight sandstone horizons in Mongolia. The exploration could expand TTCBM’s longer-term potential, but the company says commercialising existing resources remains the immediate priority.

Orthocell has recorded the first commercial sales of its Remplir nerve repair product in Thailand, opening a new market estimated at US$84 million. The launch gives the company another distributor-led growth channel, although near-term sales are expected to remain modest.

Neurotech International has dosed the first patient in its pivotal Phase 3 Beyond Harmony study of NTI164, moving the autism therapy into its most consequential clinical test yet. The trial plans to enrol up to 200 children across six Australian sites, but no Phase 3 efficacy data are available at this stage.

BluGlass has begun a three-to-five-month, A$286,000 feasibility collaboration with global photonics company Coherent to develop a novel gallium nitride device for scientific and medical applications. The agreement offers technical and commercial promise, but does not yet include a production commitment or confirmed product launch.

AdAlta says a 10-year, up to US$120 million agreement between manufacturing partner Oribiotech and an undisclosed commercial-stage biopharmaceutical company validates its choice of IRO automation for future cellular immunotherapies. The deal does not create direct revenue for AdAlta, and its lead asset EW-001 will continue with a separate manufacturing process.

Central Petroleum has swung to a $4.9 million FY2026 statutory loss after writing down two Amadeus Basin permits, but its gas business generated higher revenue and margins. The company is now betting on Palm Valley drilling, long-term contracts and new east coast acreage to restore growth.

Condor Energy has consolidated 100% ownership of its offshore Peru acreage and moved its 1 Tcf Piedra Redonda gas discovery closer to commercialisation. The company enters FY2027 with a larger resource base and stronger project control, but auditors have warned that additional funding is needed to sustain operations.

Ionic Rare Earths is pushing toward commercial magnet recycling in Belfast and the United States, but its FY2026 report flags a material uncertainty over its ability to continue as a going concern. The company reported a larger A$14.9 million loss and A$13.9 million in operating cash outflows, despite government support and new strategic partnerships.

ABx Group has locked in approximately $4.1 million through a placement and fully underwritten share purchase plan, with strategic partner Good Importing International committing $1 million. The funding will support the Deep Leads rare earths project and construction and commissioning of the ALCORE pilot plant, but comes with substantial new equity and options.

Zinc of Ireland has transformed from a small Irish zinc explorer into a metals technology developer, acquiring Meclex, raising A$5.5 million and advancing ARGO and VOLTA. The opportunity is substantial, but both technologies remain uncommercialised and the VOLTA partnership requires formal renewal.

ION Video has secured an oversubscribed $4.25 million placement to fund independent trials of its video technology, with directors and management committing a further $1.2 million subject to shareholder approval. The capital will be used to test whether ION’s architecture can deliver measurable technical and financial benefits in real operating environments.